The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded a decrease of -66.76%. However, over the last six months, the performance has been stronger by -55.52%. The price of SLRX increased 4.64% over the last 30 days. And in the last five days, it has fallen by -13.82%.
In terms of market performance, Salarius Pharmaceuticals Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $7.20 on 01/13/25, while the lowest value was $0.45 on 04/09/25.
52-week price history of SLRX Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Salarius Pharmaceuticals Inc’s current trading price is -89.50% away from its 52-week high, while its distance from the 52-week low is 67.32%. The stock’s price range over this timeframe has been between $0.45 and $7.20. The shares of the Healthcare sector company recorded a trading volume of approximately 1.08 million for the day, which was comparatively lower than the average daily volume of 1.21 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Salarius Pharmaceuticals Inc (SLRX) has experienced a quarterly rise of 5.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.61M and boasts a workforce of 2 employees.
How Moving Averages and Trading Volume Data Work Together
SLRX’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for SLRX stands at 1.83. Similarly, the long-term debt-to-equity ratio is also 0.00.
